Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond

Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond

Date: Tuesday, 1 March 2022 - Wednesday, 2 March 2022
Location: Rotterdam, The Netherlands


Conference Chair

Holger Becker

Holger Becker
Chief Scientific Officer, microfluidic ChipShop GmbH

Keynote Speakers

Danilo Tagle

Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology

Emmanuel Delamarche

Emmanuel Delamarche
Senior Manager, Spiden AG

Overview

The SARS-CoV-2 Coronavirus Pandemic is evolving and the various variants which currently are driving the pandemic forward are responsible for morbidity, mortality and economic strains globally.

This 2-day conference held onsite as a regular physical conference at the Hilton Rotterdam, The Netherlands takes a deep dive on the current role of Microfluidics Technologies in SARS-CoV-2 testing (circa 2022) and expectations for the future role of Microfluidics in the Management of Pandemics.

The conference brings together companies engaged in this space from the larger diagnostics companies to the emerging companies providing technical solutions in this field -- Providing them a platform to present their technology/offering to the community and engage.

In addition to presentations, there will be posters to highlight technologies and late-breaking developments.

This conference is chaired by Dr. Holger Becker, Chief Scientific Officer and Co-Founder of microfluidic ChipShop GmbH and a key opinion leader in the microfluidics and lab-on-a-chip field.

Agenda Topics

  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
  • Lateral Flow Assays
  • Microfluidics Impact on SARS-CoV-2 Testing: Current Status and Future
    • Technical Solutions for Rapid COVID-19 Testing
  • Nucleic Acid Diagnostic Tests and Rapid Testing: Evolution of the Space
  • Organoids and Organs-on-Chips to Model SARS-CoV-2 Infection Ex Vivo
  • Rapid Biodetection of Pathogens and Threat Identification: Pandemics and Biosurveillance
  • SARS-CoV-2 Rapid Diagnostics and Global Health
  • Vaccine Development

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

James Boiani, Partner, Epstein Becker & Green, P.C.
Yongsheng Cheng, CEO and Co-founder, PixelBiotech GmbH
Andrea Chow, Senior Vice President of Engineering, Ontera Inc.
Peter Ertl, Professor of Lab-on-a-Chip Systems, Vienna University of Technology
Jonathan D Posner, Professor of Mechanical Engineering & Chemical Engineering, University of Washington
Jun Ho Son, CTO, Kryptos Biotechnologies, Inc.
Mickey Urdea, Founding Partner & Principal, Halteres Associates
Paul Yager, Professor, Department of Bioengineering, University of Washington


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Agenda is not currently available
Add to Calendar ▼2022-03-01 00:00:002022-03-02 00:00:00Europe/LondonMicrofluidics to Address Pandemics - SARS-CoV-2 and BeyondMicrofluidics to Address Pandemics - SARS-CoV-2 and Beyond in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com